Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin versus crystalloid for emergency department sepsis resuscitation
ACTRN12621000036819Phase 4Completed
- Sponsor
- Royal Brisbane and Women's Hospital
- Start
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of albumin (human) in sepsis and Infection (2 arms), sponsored by Royal Brisbane and Women's Hospital. Primary endpoint: Systolic blood pressure. Started Jan 2021; status: completed.
02
Drugs
albumin (human)
03
Conditions
sepsisInfection
Beyond the preview
Go deeper on ACTRN12621000036819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000036819.